Results 1 to 10 of about 5,627,596 (250)

Tumor Necrosis Factor and Splenectomy

open access: yesTurkish Journal of Hematology, 2016
Banyatsuppasin et al. suggested the role of the spleen in controlling mononuclear phagocytic activity in E/b-Thal patients [6]. TNF-α play roles as an inducer and effector of monocyte activation [6]. Additionally, TNF-α returned to normal after 12, 6, and 3 months of deferiprone treatment [7].
İrfan Yavaşoğlu
doaj   +3 more sources

Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation

open access: yesNature Communications, 2018
Anti-TNF therapy has improved the treatment of inflammatory disease but can predispose to infection and malignancy. Here the authors show an anti-TNF biologic peptide that functionally and selectively targets the TNF-p38 pathway in multiple models of ...
Violet R. Mukaro   +9 more
doaj   +2 more sources

Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis

open access: yesTherapeutics and Clinical Risk Management, 2008
José Luis Callejas-Rubio, Lourdes López-Pérez, Norberto Ortego-CentenoUnit of Autoimmune Systemic Diseases, Hospital Clinico San Cecilio, Granada, SpainAbstract: Sarcoidosis is a chronic multisystem disease of unknown ...
José Luis Callejas-Rubio   +2 more
doaj   +1 more source

Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis

open access: yesPatient Preference and Adherence, 2013
Virginia Martínez-Santana,1 E González-Sarmiento,2 MA Calleja-Hernández,3 T Sánchez-Sánchez1 1Pharmacy Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain; 2Internal Medicine Department ...
Martínez-Santana V   +3 more
doaj   +3 more sources

Non-tumor necrosis factor-based biologic therapies for rheumatoid arthritis: present, future, and insights into pathogenesis

open access: yesBiologics: Targets & Therapy, 2013
Filipe Seguro Paula,1 José Delgado Alves1,2 1Immunomediated Systemic Diseases Unit, Department of Medicine 4, Fernando Fonseca Hospital, Amadora, 2Center for the Study of Chronic Diseases, Department of Pharmacology, Faculty of Medical Sciences ...
Paula FS, Delgado Alves J
doaj   +1 more source

Comparative Analysis of TNF-alpha, TNF-R1, and TNF-R2 in Patients with Low-impact Fractures Due to Osteoporosis [PDF]

open access: yesRevista Brasileira de Ortopedia, 2023
Objective To analyze the serum levels of TNF-alpha and its TNF-R1 and TNF-R2 receptors in the blood of patients with low-impact fractures due to osteoporosis, comparing between genders and with healthy patients. Methods The present study was conducted
Abel Oliveira Marques Teixeira   +5 more
doaj   +1 more source

Tumor necrosis factor [PDF]

open access: yesCancer Letters, 2013
Tumor necrosis factor (TNF) is a critical cytokine, which contributes to both physiological and pathological processes. This mini-review will briefly touch the history of TNF discovery, its family members and its biological and pathological functions. Then, it will focus on new findings on the molecular mechanisms of how TNF triggers activation of the ...
F. Atzeni, P. Sarzi-Puttini
openaire   +3 more sources

Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk [PDF]

open access: yesCurrent Medical Research and Opinion, 2015
Tumor necrosis factor (TNF) is a highly pleiotropic cytokine with multiple activities other than its originally discovered role of tumor necrosis in rodents. TNF is now understood to play a contextual role in driving either tumor elimination or promotion.
Hervé, Lebrec   +5 more
openaire   +2 more sources

Tumor Necrosis Factor Alpha Signaling and Organogenesis

open access: yesFrontiers in Cell and Developmental Biology, 2021
Tumor necrosis factor alpha (TNF-α) plays important roles in processes such as immunomodulation, fever, inflammatory response, inhibition of tumor formation, and inhibition of viral replication.
Kai You   +4 more
doaj   +1 more source

Transmembrane tumor necrosis factor alpha attenuates pressure-overload cardiac hypertrophy via tumor necrosis factor receptor 2.

open access: yesPLoS Biology, 2020
Tumor necrosis factor-alpha (TNF-α) plays an important pathogenic role in cardiac hypertrophy and heart failure (HF); however, anti-TNF is paradoxically negative in clinical trials and even worsens HF, indicating a possible protective role of TNF-α in HF.
Kun Miao   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy